Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mckesson Corp. (MCK)
NYSE:MCK
Holding MCK?
Track your performance easily
MCK Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$431.35 - $637.51
Previous Close$511.62
Volume862.81K
Average Volume (3M)906.07K
Market Cap
$66.35B
Enterprise Value$71.81B
Total Cash (Recent Filing)$2.30B
Total Debt (Recent Filing)$7.40B
Price to Earnings (P/E)23.0
Beta0.26
Next Earnings
Oct 29, 2024EPS Estimate
$7.03Last Dividend Ex-Date
Aug 30, 2024Dividend Yield0.5%
Share Statistics
EPS (TTM)22.36
Shares Outstanding129,676,762
10 Day Avg. Volume1,361,123
30 Day Avg. Volume906,071
Standard Deviation0.06
R-Squared0.14
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)-37.81
Price to Sales (P/S)0.21
Price to Cash Flow (P/CF)-12.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.23
Enterprise Value/Gross Profit5.60
Enterprise Value/Ebitda15.02
Forecast
1Y Price Target
$628.09Price Target Upside23.60% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering13
McKesson News
Bulls Say, Bears Say
Bulls Say
Market PositionThe addition of the Optum contract will accelerate both revenue and earnings growth, enhancing McKesson’s robust position in the pharma market.
Operational FocusThe sale of its Canada-based Rexall and Well.ca businesses allows McKesson to manage its SG&A more effectively and focus on high-performing US operations.
Strategic InvestmentsMcKesson's acquisition of Florida Cancer Specialists adds an estimated $3.6 billion of oncology spend to its platform, reinforcing its focus on high-growth areas.
Bears Say
EarningsThe company missed revenue, adjusted operating income, and EPS excluding the gain.
Revenue GuidanceMCK lowered revenue guidance in U.S. Pharmaceutical, RxTs, and Medical-Surgical segments.
Segment PerformanceMed/Surg and RxTS missed expectations in the quarter, owing somewhat to timing but also with a slight guide-down on segment EBIT.
---
Ownership Overview
0.56% Insiders
23.79% Mutual Funds
37.85% Other Institutional Investors
37.80% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
ProductionRisks related to the company’s ability to manufacture goods and services
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MCK FAQ
What was Mckesson Corp.’s price range in the past 12 months?
Mckesson Corp. lowest stock price was $431.35 and its highest was $637.51 in the past 12 months.
What is Mckesson Corp.’s market cap?
Currently, no data Available
When is Mckesson Corp.’s upcoming earnings report date?
Mckesson Corp.’s upcoming earnings report date is Oct 29, 2024 which is in 39 days.
How were Mckesson Corp.’s earnings last quarter?
Mckesson Corp. released its earnings results on Aug 07, 2024. The company reported $7.88 earnings per share for the quarter, beating the consensus estimate of $7.209 by $0.671.
Is Mckesson Corp. overvalued?
According to Wall Street analysts Mckesson Corp.’s price is currently Undervalued.
Does Mckesson Corp. pay dividends?
Mckesson Corp. pays a Quarterly dividend of $0.71 which represents an annual dividend yield of 0.5%. See more information on Mckesson Corp. dividends here
What is Mckesson Corp.’s EPS estimate?
Mckesson Corp.’s EPS estimate is $7.03.
How many shares outstanding does Mckesson Corp. have?
Mckesson Corp. has 129,676,760 shares outstanding.
What happened to Mckesson Corp.’s price movement after its last earnings report?
Mckesson Corp. reported an EPS of $7.88 in its last earnings report, beating expectations of $7.209. Following the earnings report the stock price went down -11.336%.
Which hedge fund is a major shareholder of Mckesson Corp.?
Among the largest hedge funds holding Mckesson Corp.’s share is Lone Pine Capital LLC. It holds Mckesson Corp.’s shares valued at 328M.
---
McKesson Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$628.09 (23.60% Upside)
$628.09 (23.60% Upside)
Blogger Sentiment
Bullish
MCK Sentiment 92%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 429.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.5%
Last 30 Days ▼ 1.1%
Last 30 Days ▼ 1.1%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
20.32%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
11.82%
Trailing 12-Months
Company Description
Mckesson Corp.
Incorporated in 1833, Texas-based McKesson Corp. provides pharmaceuticals, health information technology, medical supplies, and care management tools. The company operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions, International, and Medical-Surgical Solutions.
---
MCK Company Deck
---
MCK Earnings Call
Q1 2024
0:00 / 0:00
---
MCK Revenue Breakdown
90.22% U.S. Pharmaceutical
4.57% International
3.66% Medical-Surgical Solutions
1.54% Prescription Technology Solutions
---
MCK Stock 12 Month Forecast
Average Price Target
$628.09
▲(23.60% Upside)
Technical Analysis
Best Analysts Covering MCK
1 Year
1 Year Success Rate
16/20 ratings generated profit
1 Year Average Return
+27.73%
reiterated a buy rating 5 months ago
Copying Kevin Caliendo's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +27.73% per trade.
---